Our research into biomarkers
Biomarkers are substances that doctors can measure, for example in samples of blood or urine, which help them monitor how a disease is developing or whether a treatment is working. By testing for certain molecules in the bloodstream, it’s becoming possible to detect some types of cancer at an early stage, when they are more likely to be treated successfully. Biomarkers are also essential for monitoring a patient’s cancer, to see how it responds to treatment.
Cancer Research UK scientists are looking for new biomarkers, and trying to find ways to improve existing ones.
Finding new biomarkers is crucial in the drive to more ‘personalised’ cancer care. Together with our growing understanding of the genetic changes that contribute to cancer, biomarker research will lead to targeted screening programmes and better ways to treat and monitor individual patients.
Below are some of the highlights of our biomarker research portfolio.
Wellcome Trust Sanger Institute
University of Leeds
University of Southampton
Queen's University of Belfast
Queen Mary, University of London
Institute of Cancer Research
University College London